# Heterogeneity of resistance mutations detectable by next-generation sequencing in TKI-treated lung adenocarcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/heterogeneity-of-resistance-mutations-detectable-by-next-generation-sequencing/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Deborah Belchis,Li‐Hui Tseng,Thomas J. Gniadek,Lisa Haley,Parvez M. Lokhandwala,Peter B. Illei,Christopher D. Gocke,Patrick M. Forde,Julie R. Brahmer,Frederic B. Askin,James R. Eshleman,Ming‐Tseh Lin |
| Citations | 28 |
| DOI | 10.18632/oncotarget.9931 |
| Fields | Biochemistry, Genetics and Molecular Biology,Chemistry,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=9931&path%5B%5D=31200 |
| OpenAlex ID | https://openalex.org/W2417629186 |
| PMID | 27304188 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Julie R. Brahmer](https://scholariq.org/researchers/julie-r-brahmer/)
- [Peter B. Illei](https://scholariq.org/researchers/peter-b-illei/)
- [Frederic B. Askin](https://scholariq.org/researchers/frederic-b-askin/)
- [Patrick M. Forde](https://scholariq.org/researchers/patrick-m-forde/)
- [James R. Eshleman](https://scholariq.org/researchers/james-r-eshleman/)

## Paper funders

- [National Institutes of Health](https://scholariq.org/funders/national-institutes-of-health/)
- [National Cancer Institute](https://scholariq.org/funders/national-cancer-institute/)

## Paper journal

- [Oncotarget](https://scholariq.org/journals/oncotarget/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Quinazolinone synthesis and applications](https://scholariq.org/topics/quinazolinone-synthesis-and-applications/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.